Although left sided heart failure and left ventricular malfunctioning is more common than right sided heart failure and right ventricular malfunctioning, heart failure can be both right sided and left sided.

Stage C contains sufferers with structural heart illness with existing or prior symptomatic heart failure.

Stage C includes patients with structural heart disease with current or prior symptomatic heart failure.

Patients with Stage C heart failure have a structural abnormality of the heart and current or previous symptoms of heart failure.

The system particularly identifies those patients who are at increased risk for sudden cardiac death based upon a history of a prior heart attack and left ventricular dysfunction.

Important prognostic variables include the degree of left and right ventricular dysfunction, heart block, and specific histopathological forms of myocarditis.

A multicentre, randomised, double-blind, placebo-controlled trial (SOLVD Prevention trial) examined a population with asymptomatic left ventricular dysfunction (LVEF<35%).

Important prognostic variables include the presence of heart block, degree of left and right ventricular dysfunction, and specific histopathological forms of myocarditis.

Valsartan is used to treat high blood pressure, congestive heart failure, and to reduce death for people with left ventricular dysfunction after having had a heart attack.[1][2]

Valsartan is used to treat high blood pressure, congestive heart failure, and to reduce death for people with left ventricular dysfunction after having had a heart attack.

This is evident in a British study published in Diabetes Care that analyzed left ventricular dysfunction studies involving 4,223 diabetics and non-diabetics.